Sanofi Licenses an Undisclosed Nurix Therapeutics’ Drug Program for Autoimmune Diseases
Shots: Sanofi has licensed an undisclosed Nurix program targeting a previously und...
Ono Enters into an Option Agreement with Reborna Biosciences for RNA-Targeting Small Molecule to treat CNS Disorders
Shots: Ono Pharmaceutical entered into an option agreement to obtain exclusive rig...
Lexicon Enters a Global Licensing Agreement with Novo Nordisk for LX9851
Shots: Lexicon has granted Novo Nordisk exclusive global rights to develop, manufa...
Ionis Partners with Sobi for Olezarsen to Treat Familial Chylomicronemia Syndrome (FCS) & Severely Elevated Triglycerides
Shots: Ionis has granted Sobi global exclusive rights of olezarsen excl. the US, C...
Bayer Enters Global License Agreement with Suzhou Puhe BioPharma for its PRMT5 Inhibitor
Shots: Bayer & Suzhou Puhe BioPharma have entered into a global license agreem...
Merck Partners with Jiangsu Hengrui Pharmaceuticals for HRS-5346, Expanding its Cardio-Metabolic Portfolio
Shots: Merck has entered into an exclusive license agreement with Jiangsu Hengrui...
